Heather White
Chief Tech/Sci/R&D Officer bei ALBIREO PHARMA, INC.
Profil
Heather White is currently the SVP-Clinical Development Operations R&D at Albireo Pharma, Inc. She previously worked as a Senior Director at Amicus Therapeutics, Inc., Vice President-Global Internal Audit at Ipsen SA, and Head-Medical Affairs at Schering-Plough Ltd.
Ms. White received her undergraduate and graduate degrees from The University of Liverpool.
Aktive Positionen von Heather White
| Unternehmen | Position | Beginn |
|---|---|---|
| ALBIREO PHARMA, INC. | Chief Tech/Sci/R&D Officer | 02.03.2023 |
Ehemalige bekannte Positionen von Heather White
| Unternehmen | Position | Ende |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Director/Board Member | - |
Schering-Plough Ltd.
 Schering-Plough Ltd. Pharmaceuticals: MajorHealth Technology Schering-Plough Ltd. manufactures and distributes pharmaceutical products. Its products include medicines for vascular diseases, oncology, opioid tendency, sexual health and virology. The company was founded on December 31, 1884 and is headquartered in Walton, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
| IPSEN | Comptroller/Controller/Auditor | - |
Ausbildung von Heather White
| The University of Liverpool | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMICUS THERAPEUTICS, INC. | Health Technology |
| IPSEN | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Schering-Plough Ltd.
Schering-Plough Ltd. Pharmaceuticals: MajorHealth Technology Schering-Plough Ltd. manufactures and distributes pharmaceutical products. Its products include medicines for vascular diseases, oncology, opioid tendency, sexual health and virology. The company was founded on December 31, 1884 and is headquartered in Walton, the United Kingdom. | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
